In Vivo Ocular Fluorophotometry: Delivery of Fluoresceinated Dextrans Via Transscleral Diffusion in Rabbits
Overview
Affiliations
Purpose: To evaluate the transscleral delivery of fluoresceinated dextrans (FITC-D) with molecular mass up to 70 kDa to the rabbit posterior segment using sub-Tenon injections.
Methods: Eighteen NZW rabbits received a unilateral 200-μL injection of 2 mg/mL sodium fluorescein (NaF), 25 mg/mL 40-kDa FITC-D, or 25 mg/mL 70-kDa FITC-D, with (n = 9) or without (n = 9) immediate euthanatization. In live animals, fluorescence was measured in the retina/choroid and mid-vitreous by fluorophotometry, immediately after injection and after 4, 24, 48, and 72 hours. Euthanatized animals were examined hourly through 5 or 6 hours.
Results: In live animals, the average peak NaF concentration in the retina/choroid was 310.2 ng/mL, measured 3 hours after injection. Average 40- and 70-kDa FITC-D concentrations in the retina/choroid peaked at 5409.6 and 2375.6 ng/mL, respectively, 24 hours after injection. Fluorescence returned to baseline levels 6 hours after NaF injection, and 48 and 72 hours after 40- and 70-kDa FITC-D injections, respectively. Rabbits that received NaF followed by euthanatization exhibited a continuous increase in retina/choroid and mid-vitreous fluorescence, beginning 1 hour after injection, whereas FITC-D-injected eyes did not show elevated retina/choroid or mid-vitreous fluorescence through 6 hours.
Conclusions: FITC-D weighing up to 70-kDa, as well as NaF, reached the posterior retina/choroid after sub-Tenon injections in live rabbits. NaF and 40-kDa FITC-D reached higher peak concentrations and were cleared from the eye more rapidly than was 70-kDa FITC-D. There was minimal penetration of NaF and FITC-D into the mid-vitreous in the in vivo experiments.
Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods.
Bora K, Kushwah N, Maurya M, Pavlovich M, Wang Z, Chen J Cells. 2023; 12(20).
PMID: 37887287 PMC: 10605292. DOI: 10.3390/cells12202443.
Iselin K, Thiel M, Bachmann L, Baenninger P, Kaufmann C Transl Vis Sci Technol. 2019; 8(6):7.
PMID: 31737431 PMC: 6855370. DOI: 10.1167/tvst.8.6.7.
Ocular Biodistribution Studies using Molecular Imaging.
Castro-Balado A, Mondelo-Garcia C, Gonzalez-Barcia M, Zarra-Ferro I, Otero-Espinar F, Ruibal-Morell A Pharmaceutics. 2019; 11(5).
PMID: 31100961 PMC: 6572242. DOI: 10.3390/pharmaceutics11050237.
Papangkorn K, Higuchi J, Brar B, Higuchi W J Ocul Pharmacol Ther. 2018; 34(4):325-334.
PMID: 29432054 PMC: 5952332. DOI: 10.1089/jop.2017.0093.
Papangkorn K, Prendergast E, Higuchi J, Brar B, Higuchi W J Ocul Pharmacol Ther. 2017; 33(10):753-762.
PMID: 29022761 PMC: 5733740. DOI: 10.1089/jop.2017.0053.